Loading provider…
Loading provider…
Gynecologic Oncology Physician in Morgantown, WV
NPI: 1174727770Primary Practice Location
WEST VIRGINIA UNIVERSITY HOSPITALS, INC
1 Medical Center Dr, Morgantown, WV
Primary Employer
University Health Associates
wvumedicine.org
HQ Phone
Get MD Kristy's Phone Numberphone_androidMobile
Get MD Kristy's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
FL State Medical License
WV State Medical License

American Board of Obstetrics and Gynecology
Gynecologic Oncology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 23 | 30 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 22 | 33 |
Using Social Marketing Theory as a Framework for Understanding and Increasing HPV Vaccine Series Completion Among Hispanic Adolescents: A Qualitative Study.
Authors: Angelica Roncancio, Kristy Ward, Chakema Carmack, Becky Muñoz, Miguel Cano, Felicity Cribbs
Publication Date: 2016-09-15
Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.
Authors: Shah, Nina R, Tancioni, Isabelle, Ward, Kristy K, Lawson, Christine, Chen, Xiao Lei, Jean, Christine, Sulzmaier, Florian J, Uryu, Sean, Miller, Nichol L G, Connolly, Denise C, Schlaepfer, David D
Journal: Gynecol Oncol
Publication Date: 2014-04-27
FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth.
Authors: Isabelle Tancioni, Sean Uryu, Florian Sulzmaier, Nina Shah, Christine Lawson, Nichol L Miller, Christine Jean, Xiao Chen, Kristy Ward, David Schlaepfer
Publication Date: 2014-06-06
Lead Sponsor: AbbVie
Collaborators: Gynecologic Oncology Group, European Network of Gynaecological Oncological Trial Groups (ENGOT)
Intervention / Treatment: DRUG: Paclitaxel, DRUG: Topotecan, DRUG: Mirvetuximab Soravtansine, DRUG: Pegylated liposomal doxorubicin
Lead Sponsor: ImmunoGen, Inc.
Intervention / Treatment: DRUG: Mirvetuximab Soravtansine
Lead Sponsor: NovoCure Ltd.
Intervention / Treatment: DRUG: Paclitaxel, DEVICE: NovoTTF-100L(O)